BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30685661)

  • 1. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
    Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
    Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.
    Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F
    Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit.
    Richardson MT; Mysona DP; Klein DA; Mann A; Liao CI; Diver EJ; Darcy KM; Tian C; She JX; Ghamande S; Van Le L; Kapp DS; Chan JK
    Gynecol Oncol; 2020 Oct; 159(1):118-128. PubMed ID: 32828578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.
    Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB
    Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
    Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer.
    Hirose S; Tanabe H; Nagayoshi Y; Hirata Y; Narui C; Ochiai K; Isonishi S; Takano H; Okamoto A
    J Gynecol Oncol; 2018 May; 29(3):e37. PubMed ID: 29533021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.
    Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA
    Gynecol Oncol; 2019 Aug; 154(2):302-307. PubMed ID: 31155308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
    Imterat M; Bizzarri N; Fruscio R; Perrone AM; Traut A; du Bois A; Rosati A; Ferrari D; De Iaco P; Ataseven B; Ergasti R; Volontè S; Tesei M; Heitz F; Perri MT; Concin N; Fanfani F; Scambia G; Fagotti A; Harter P
    Int J Gynecol Cancer; 2023 Jan; 33(1):42-49. PubMed ID: 36104079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
    Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
    Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
    Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
    Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
    Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
    Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Cyst Emptying, Lymph Node Resection and Chemotherapy on Survival in Stage IA and IC1 Epithelial Ovarian Cancer.
    Rosendahl M; Mosgaard BJ; Høgdall C
    Anticancer Res; 2016 Oct; 36(10):5373-5379. PubMed ID: 27798901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.